| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antibody-dependent cell-mediated cytotoxicity induced by active immunotherapy based on racotumomab in non-small cell lung cancer patients
|
Segatori, Valeria I.
|
|
2018
|
67 |
8 |
p. 1285-1296
|
artikel
|
| 2 |
Bispecific light T-cell engagers for gene-based immunotherapy of epidermal growth factor receptor (EGFR)-positive malignancies
|
Mølgaard, Kasper
|
|
2018
|
67 |
8 |
p. 1251-1260
|
artikel
|
| 3 |
Differential regulation of human monocytes and NK cells by antibody-opsonized tumors
|
Yin, Jun
|
|
2018
|
67 |
8 |
p. 1239-1250
|
artikel
|
| 4 |
Establishment of adoptive cell therapy with tumor infiltrating lymphocytes for non-small cell lung cancer patients
|
Ben-Avi, Ronny
|
|
2018
|
67 |
8 |
p. 1221-1230
|
artikel
|
| 5 |
Expression of CD3, PD-L1 and CTLA-4 in mammary and extra-mammary Paget disease
|
Karpathiou, Georgia
|
|
2018
|
67 |
8 |
p. 1297-1303
|
artikel
|
| 6 |
Immune checkpoint blockade therapy of mesothelioma: a clinical and radiological challenge
|
Calabrò, Luana
|
|
2018
|
67 |
8 |
p. 1317-1324
|
artikel
|
| 7 |
Immune-mediated cholangitis: is it always nivolumab’s fault?
|
Gelsomino, Francesco
|
|
2018
|
67 |
8 |
p. 1325-1327
|
artikel
|
| 8 |
Indoleamine 2,3-dioxygenase provides adaptive resistance to immune checkpoint inhibitors in hepatocellular carcinoma
|
Brown, Zachary J.
|
|
2018
|
67 |
8 |
p. 1305-1315
|
artikel
|
| 9 |
Inhibition of the adenosine A2a receptor modulates expression of T cell coinhibitory receptors and improves effector function for enhanced checkpoint blockade and ACT in murine cancer models
|
Leone, Robert D.
|
|
2018
|
67 |
8 |
p. 1271-1284
|
artikel
|
| 10 |
Longitudinal studies of the 18F-FDG kinetics after ipilimumab treatment in metastatic melanoma patients based on dynamic FDG PET/CT
|
Sachpekidis, Christos
|
|
2018
|
67 |
8 |
p. 1261-1270
|
artikel
|
| 11 |
Merkel cell carcinoma and cellular cytotoxicity: sensitivity to cellular lysis and screening for potential target antigens suitable for antibody-dependent cellular cytotoxicity
|
Ollier, Jocelyn
|
|
2018
|
67 |
8 |
p. 1209-1219
|
artikel
|
| 12 |
Occurrence of type 1 and type 2 diabetes in patients treated with immunotherapy (anti-PD-1 and/or anti-CTLA-4) for metastatic melanoma: a retrospective study
|
Gauci, Marie-Léa
|
|
2018
|
67 |
8 |
p. 1197-1208
|
artikel
|
| 13 |
Randomized controlled phase III trial of adjuvant chemoimmunotherapy with activated cytotoxic T cells and dendritic cells from regional lymph nodes of patients with lung cancer
|
Kimura, Hideki
|
|
2018
|
67 |
8 |
p. 1231-1238
|
artikel
|
| 14 |
Response to “Immune-mediated cholangitis: is it always nivolumab’s fault?”
|
Kashima, Jumpei
|
|
2018
|
67 |
8 |
p. 1329-1330
|
artikel
|
| 15 |
Targeting myeloid-derived suppressor cells for cancer immunotherapy
|
Liu, Yijun
|
|
2018
|
67 |
8 |
p. 1181-1195
|
artikel
|
Tijdschrift beschrijving